New target genes for NOV/CCN3 in chondrocytes: TGF-beta2 and type X collagen - PubMed (original) (raw)
. 2005 Dec;20(12):2213-23.
doi: 10.1359/JBMR.050818. Epub 2005 Aug 22.
Affiliations
- PMID: 16294274
- DOI: 10.1359/JBMR.050818
Free article
New target genes for NOV/CCN3 in chondrocytes: TGF-beta2 and type X collagen
Jerome Lafont et al. J Bone Miner Res. 2005 Dec.
Free article
Erratum in
- J Bone Miner Res. 2006 Feb;21(2):352
Abstract
We studied the involvement of NOV/CCN3, whose function is poorly understood, in chondrocyte differentiation. NOV was found to upregulate TGF-beta2 and type X collagen and to act as a downstream effector of TGF-beta1 in ATDC5 and primary chondrocytes. Thus, NOV is a positive modulator of chondrogenesis.
Introduction: NOV/CCN3 is a matricellular protein that belongs to the CCN family. A growing body of evidence indicates that NOV could play a role in cell differentiation, particularly in chondrogenesis. During chick embryo development, NOV expression is tightly regulated in cartilage, and a high expression of NOV has been associated with cartilage differentiation in Wilms' tumors. However, a precise role for NOV and potential target genes of NOV in chondrogenesis are unknown.
Materials and methods: ATDC5 cells and primary chondrocytes were either treated with NOV recombinant protein or transfected with a NOV-specific siRNA to determine, using quantitative RT-PCR, the effect of NOV on the expression of several molecules involved in chondrocyte differentiation. Stable ATDC5 clones expressing NOV were also established to show that NOV was a downstream effector of TGF-beta1.
Results: We established that NOV/CCN3 expression increases in ATDC5 cells at early stages of chondrogenic differentiation and precedes the appearance of TGF-beta2 and of several chondrocytic markers such as SOX9 or type X collagen. When exogenously administered, NOV recombinant protein up-regulates TGF-beta2 and type X collagen mRNA levels both in ATDC5 cells and in primary mouse chondrocytes but does not influence SOX9 expression. This regulation also occurs at the endogenous level because downregulation of NOV expression is correlated with an inhibition of TGF-beta2 and type X collagen in primary chondrocytes. Furthermore, we found that NOV expression is downregulated when chondrocytes are exposed to TGF-beta1-dedifferentiating treatment in chondrocytes, further providing evidence that NOV may counteract TGF-beta1 effects on chondrocytes.
Conclusions: This study provides the first characterization of two new targets of NOV involved in chondrocyte differentiation, shows that NOV acts with TGF-beta1 in a cascade of gene regulation, and indicates that NOV is a positive modulator of chondrogenesis.
Similar articles
- Chondrogenic differentiation of bovine bone marrow mesenchymal stem cells (MSCs) in different hydrogels: influence of collagen type II extracellular matrix on MSC chondrogenesis.
Bosnakovski D, Mizuno M, Kim G, Takagi S, Okumura M, Fujinaga T. Bosnakovski D, et al. Biotechnol Bioeng. 2006 Apr 20;93(6):1152-63. doi: 10.1002/bit.20828. Biotechnol Bioeng. 2006. PMID: 16470881 - Connective tissue growth factor (CTGF) acts as a downstream mediator of TGF-beta1 to induce mesenchymal cell condensation.
Song JJ, Aswad R, Kanaan RA, Rico MC, Owen TA, Barbe MF, Safadi FF, Popoff SN. Song JJ, et al. J Cell Physiol. 2007 Feb;210(2):398-410. doi: 10.1002/jcp.20850. J Cell Physiol. 2007. PMID: 17111364 - Paracrine and autocrine signals promoting full chondrogenic differentiation of a mesoblastic cell line.
Locker M, Kellermann O, Boucquey M, Khun H, Huerre M, Poliard A. Locker M, et al. J Bone Miner Res. 2004 Jan;19(1):100-10. doi: 10.1359/JBMR.0301206. J Bone Miner Res. 2004. PMID: 14753742 - [Transcriptional regulation in chondrogenesis by Sox9].
Akiyama H. Akiyama H. Clin Calcium. 2011 Jun;21(6):845-51. Clin Calcium. 2011. PMID: 21628799 Review. Japanese. - [Analysis of chondrocyte differentiation using chondrocyte-specific genetically modified mice].
Tsumaki N. Tsumaki N. Clin Calcium. 2011 Jun;21(6):839-44. Clin Calcium. 2011. PMID: 21628798 Review. Japanese.
Cited by
- CCN3/NOV serum levels in coronary artery disease (CAD) patients and its correlation with TNF-α and IL-6.
Fadhil Jaafar A, Afrisham R, Fadaei R, Farrokhi V, Moradi N, Abbasi A, Einollahi N. Fadhil Jaafar A, et al. BMC Res Notes. 2023 Nov 2;16(1):306. doi: 10.1186/s13104-023-06590-x. BMC Res Notes. 2023. PMID: 37919772 Free PMC article. - Exposure of primary osteoblasts to combined magnetic and electric fields induced spatiotemporal endochondral ossification characteristic gene- and protein expression profiles.
Dittmann KH, Mayer C, Stephan H, Mieth C, Bonin M, Lechmann B, Rodemann HP. Dittmann KH, et al. J Exp Orthop. 2022 May 2;9(1):39. doi: 10.1186/s40634-022-00477-9. J Exp Orthop. 2022. PMID: 35499653 Free PMC article. - CCN proteins in the musculoskeletal system: current understanding and challenges in physiology and pathology.
Giusti V, Scotlandi K. Giusti V, et al. J Cell Commun Signal. 2021 Dec;15(4):545-566. doi: 10.1007/s12079-021-00631-5. Epub 2021 Jul 6. J Cell Commun Signal. 2021. PMID: 34228239 Free PMC article. Review. - CCN4/WISP-1 positively regulates chondrogenesis by controlling TGF-β3 function.
Yoshioka Y, Ono M, Maeda A, Kilts TM, Hara ES, Khattab H, Ueda J, Aoyama E, Oohashi T, Takigawa M, Young MF, Kuboki T. Yoshioka Y, et al. Bone. 2016 Feb;83:162-170. doi: 10.1016/j.bone.2015.11.007. Epub 2015 Nov 10. Bone. 2016. PMID: 26555637 Free PMC article. - RNA Seq profiling reveals a novel expression pattern of TGF-β target genes in human blood eosinophils.
Shen ZJ, Hu J, Esnault S, Dozmorov I, Malter JS. Shen ZJ, et al. Immunol Lett. 2015 Sep;167(1):1-10. doi: 10.1016/j.imlet.2015.06.012. Epub 2015 Jun 22. Immunol Lett. 2015. PMID: 26112417 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials